Microglia polarization

Microglia polarization describes the process by which microglial cells shift between distinct functional phenotypes in response to environmental cues. Traditionally viewed as a spectrum between the pro-inflammatory, neurotoxic M1 phenotype and the anti-inflammatory, neuroprotective M2 phenotype, this polarization influences the progression and outcome of numerous central nervous system diseases. M1 microglia, activated by signals like interferon-γ and lipopolysaccharide, produce pro-inflammatory mediators such as TNF-α, IL-1β, and reactive oxygen species, contributing to neuronal damage and exacerbation of disorders like Alzheimer's and Parkinson's diseases. In contrast, M2 microglia, typically induced by cytokines such as IL-4 and IL-13, secrete anti-inflammatory factors (e.g., IL-10, TGF-β) and neurotrophic molecules (e.g., brain-derived neurotrophic factor), facilitating tissue repair and resolution of inflammation. Microglia polarization is regulated by complex intracellular pathways and is a promising therapeutic concept, with current drug development aiming to promote beneficial (M2) polarization or reduce detrimental (M1) activation. However, it is not a single molecular entity but a cellular process critical to neuroimmunology and neurodegeneration. Note: Since "microglia polarization" is not a singular molecule, gene, or protein, but a cellular functional state, it is not listed as a canonical target in molecular drug discovery databases. Definitions, markers, and functional implications should always be interpreted accordingly.

Other names

Microglial polarizationMicroglial activation phenotypesMicroglial M1/M2 polarization

Promotion of M2 polarization (anti-inflammatory, neurotrophic); Inhibition of M1 polarization (pro-inflammatory); Modulation of signaling pathways (such as TLR4/NF-κB, JAK/STAT, PI3K/Akt, PPAR-γ)